The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  King Pharmaceuticals Inc. (KG)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
BioMed Stock Movers: DNDN, EXAS, KG

Apr 08, 2009 03:35 PM GMT
Mikerun
Return Risk
+1.04% LOW
Principal

Dendreon (DNDN) has stalled out around $6.50 per share after a major rally on news of upcoming presentation at a medical conference later this month. DNDN expects to report Provenge clinical trial results some time before the end of April, although it did not guarantee this would occur at the upcoming presentation.

The recent spike in shares of DNDN and upcoming presentation do not provide any clarity on whether Provenge results will be sufficient for attaining FDA approval and the pending data release will determine the Company's fate.

http://biomedreports.com/articles/most-popular/767-fda-calend...

King Pharma (KG) on Goldman's conviction buy list with $10 price target

Check out my article at

http://biomedreports.com/articles/most-popular/683-king-pharm...

EXACT Sciences (EXAS) moving up steadily since briefly moving below a dollar late last week. EXAS trading on light volumes this week, but moving to the upside with last trade at $1.19 today. Below is a link to my two latest articles on EXAS:

http://biomedreports.com/articles/latest-news/678-exact-scien...

Disclosure: I own shares of EXAS.


KG:  This call was made on 04/08/09 @ $7.67
Rating:   Positive   $7.67 (04/08/09)
Closed:   05/11/2009 @ $9.22 (+20.21% in 33 days)


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.56% 369
2 Gerald Greene 18.14 +69.43% 206
3 stockmarketfunding.com 17.66 +25.71% 53
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +75.75% 34


POPULAR STOCKS
Symbol Company Name Sentiment
WM Washington Mutual Inc
DRYS DryShips Inc.
DELL Dell Inc
AAPL Apple Computer Inc
BAC Bank of America Corp
YHOO Yahoo! Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
King Pharmaceuticals Inc. (KG)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
90.0%
Top:
100.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
IMUC N/A Positive n/a 11/09/09
EXAS Positive +1.52% 11/07/09
NFES N/A Positive n/a 11/07/09
ESALY N/A Negative n/a 11/04/09
PFE Negative -2.95% 11/04/09

View All >
   
Mike Havrilla previously rated KG
Positive +20.46% FDA Calendar Updates: KG, PTIE, DRRX, ALTH, TRIB, CBST, DYAX
07/07/2009
9
Positive -1.56% FDA Calendar Updates: ACUR, KG, MYRX, NEPH, Eisai
07/02/2009
9
Positive +4.45% FDA Calendar Updates: Royal Returns for King Pharma
05/11/2009
9
Positive +11.00% King Pharma: A Value Play on New Drug Approvals
03/19/2009
9
Negative -11.63% BioDelivery Sciences: A Bet on FDA Approval of Onsolis
03/05/2009
9
Neutral/Hold -25.87% FDA Decision Calendar: Pain Drug Delays Likely
02/10/2009
9
Positive -14.71% Stock Ideas from ETF Innovators New Indexes
12/07/2008
9
Positive +4.71% Full Calendar of FDA Decisions
11/30/2008
9
Positive -0.95% Stock Picks for Healthy Returns
11/25/2008
9
Positive -2.07% Full Calendar on Tap for FDA through Year-End
11/13/2008
9
Positive +10.80% More Pain to Come from the FDA?
10/22/2008
9
Positive -11.59% FDA Decision Date Calendar for 2009
09/24/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch